Schedule 13G ownership disclosure

PSYENCE BIOMEDICAL LTD

Common Shares, no par value · CUSIP: 74449F209

Event date: 2024-12-31

Filing-level shares
26,923.75
Percent of class
0.79%
  • AdvisorShares Trust

    Shares: 26,923.75 · Class: 0.79%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-25-000041
Form type
SCHEDULE 13G/A
Filer
AdvisorShares Trust
CIK
CIK 1408970
Filed
Jan 06, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub